Published in Oncol Rep on June 01, 2010
MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR. J Transl Med (2012) 1.03
Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era. J Neurooncol (2010) 1.02
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? Radiat Oncol (2011) 0.99
The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis. Fam Cancer (2013) 0.96
Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev (2012) 0.94
Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population. Am Health Drug Benefits (2014) 0.92
O6-Methylguanine-methyltransferase (MGMT) promoter methylation status in glioma stem-like cells is correlated to temozolomide sensitivity under differentiation-promoting conditions. Int J Mol Sci (2012) 0.91
Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer (2013) 0.89
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Int J Oncol (2015) 0.87
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget (2015) 0.85
A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Epigenetics (2014) 0.82
mTOR inhibition and levels of the DNA repair protein MGMT in T98G glioblastoma cells. Mol Cancer (2014) 0.78
Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature. Surg Neurol Int (2013) 0.77
Predictive value of MGMT promoter methylation status in Asian and Caucasian patients with malignant gliomas: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis. Cancer Manag Res (2017) 0.75
Safety and efficacy of RNAi therapy for transthyretin amyloidosis. N Engl J Med (2013) 3.97
Frequency of TERT promoter mutations in human cancers. Nat Commun (2013) 3.13
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today (2007) 2.50
A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Clin Cancer Res (2010) 2.37
Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. J Exp Med (2004) 2.32
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology (2012) 2.12
Histone H3.3. mutations drive pediatric glioblastoma through upregulation of MYCN. Cancer Discov (2013) 1.93
Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity (2013) 1.83
MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res (2011) 1.66
An experience sampling study of emotional reactions to music: listener, music, and situation. Emotion (2008) 1.51
Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression. Breast Cancer Res (2005) 1.47
Thalamic deep brain stimulation for neuropathic pain after amputation or brachial plexus avulsion. Neurosurg Focus (2013) 1.45
Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. PLoS One (2009) 1.44
Why do winners keep winning? Androgen mediation of winner but not loser effects in cichlid fish. Proc Biol Sci (2009) 1.44
Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease. Eur Neurol (2010) 1.40
MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature. Cancer Res (2010) 1.40
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary. Neuroendocrinology (2007) 1.40
Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study. Oncol Res Treat (2015) 1.39
Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer. BMC Cancer (2011) 1.39
Mutation analysis of B-RAF gene in human gliomas. Acta Neuropathol (2004) 1.39
Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology (2012) 1.38
Characterization of acute heart failure hospitalizations in a Portuguese cardiology department. Rev Port Cardiol (2013) 1.37
Laparoscopic placement of Tenckhoff catheters for peritoneal dialysis: a safe, effective, and reproducible procedure. Perit Dial Int (2008) 1.34
Expression of monocarboxylate transporters 1, 2, and 4 in human tumours and their association with CD147 and CD44. J Biomed Biotechnol (2010) 1.32
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma. Neuro Oncol (2011) 1.31
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro Oncol (2012) 1.29
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines. Clin Cancer Res (2009) 1.24
A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours. Eur J Cancer (2009) 1.24
Novel oncogenic PDGFRA mutations in pediatric high-grade gliomas. Cancer Res (2013) 1.23
Association between functional EGF+61 polymorphism and glioma risk. Clin Cancer Res (2007) 1.22
Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma. Cancer Res (2010) 1.21
Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer. Cancer Genomics Proteomics (2013) 1.17
Compressed mini-tablets as a biphasic delivery system. Int J Pharm (2006) 1.12
mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. J Clin Endocrinol Metab (2012) 1.08
Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One (2012) 1.04
Single pulse electrical stimulation for identification of structural abnormalities and prediction of seizure outcome after epilepsy surgery: a prospective study. Lancet Neurol (2005) 1.02
Two cases of multinodular and vacuolating neuronal tumour. Acta Neuropathol Commun (2014) 1.01
Evidence for altered neuronal organisation within the planum temporale in major psychiatric disorders. Schizophr Res (2005) 1.01
Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). J Bioenerg Biomembr (2012) 1.00
Molecular alterations of KIT oncogene in gliomas. Cell Oncol (2007) 0.99
Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas. Anticancer Res (2008) 0.98
Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. BMC Cancer (2009) 0.98
Orbital metastasis as a rare form of clinical presentation of non-small cell lung cancer. J Thorac Oncol (2007) 0.97
Surgical margin status and prognosis of gastrointestinal stromal tumor. World J Surg (2008) 0.97
Common gamma chain-signaling cytokines promote proliferation of T-cell acute lymphoblastic leukemia. Haematologica (2004) 0.96
Spontaneous hemorrhage in a lumbar ganglion cyst. Spine (Phila Pa 1976) (2008) 0.96
Insights into angiogenesis in non-small cell lung cancer: molecular mechanisms, polymorphic genes, and targeted therapies. Recent Pat Anticancer Drug Discov (2012) 0.95
Primary pineal malignant melanoma: case report and literature review. Clin Neurol Neurosurg (2010) 0.95
Evaluation of HER2 in breast cancer: reality and expectations. Expert Opin Med Diagn (2009) 0.95
Why facilitate patient access to medical records. Stud Health Technol Inform (2007) 0.94
Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Hum Mol Genet (2012) 0.94
SANDO: two novel mutations in POLG1 gene. Neuromuscul Disord (2006) 0.93
Primary spinal glioblastoma: A case report and review of the literature. Oncol Lett (2012) 0.93
Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence. Innate Immun (2012) 0.92
DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics (2007) 0.91
Gastroschisis: preterm or term delivery? Clinics (Sao Paulo) (2010) 0.91
Rib osteomyelitis in a pediatric patient case report and literature review. Pediatr Infect Dis J (2012) 0.91
Temperature induces gonadal maturation and affects electrophysiological sexual maturity indicators in Brachyhypopomus pinnicaudatus from a temperate climate. J Exp Biol (2004) 0.90
Sweet syndrome as the presenting symptom of hairy cell leukemia. Dermatol Online J (2009) 0.90
Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. J Clin Endocrinol Metab (2003) 0.90
U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma. Int J Cancer (2006) 0.89
Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation. PLoS One (2011) 0.89
Cost analysis of renal replacement therapy by transplant in a system of bundled payment of dialysis. Clin Transplant (2011) 0.89
Autophagy and inflammasome interplay. DNA Cell Biol (2015) 0.88
[Cost of cancer care in Portugal]. Acta Med Port (2009) 0.88
Molecular characterization of PDGFR-alpha/PDGF-A and c-KIT/SCF in gliosarcomas. Cell Oncol (2005) 0.88
Molecular analysis of c-Kit and PDGFRA in GISTs diagnosed by EUS. Am J Clin Pathol (2007) 0.87
Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol (2006) 0.87
Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies. Int J Pharm (2012) 0.87
KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas. J Neuropathol Exp Neurol (2015) 0.87
Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiol Biomarkers Prev (2011) 0.86
Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas. Melanoma Res (2016) 0.86
TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset. Fam Cancer (2009) 0.86